KraneShares MSCI All China Health Care Index ETFKURE
Type
ETF
Peer group
International equity
Net assets
$80.4M
Expense ratio
0.65%
1-year return
+6.6%
3 years, a year
+4.7%
5 years, a year
-12.3%
12-month yield
3.85%
Holdings
53
What it aims to do.
The KraneShares MSCI All China Health Care Index ETF (the Fund) seeks to provide investment results that, before fees and expenses, track the price and yield performance of a specific foreign equity securities index. The Funds current index is the MSCI China All Shares Health Care 10/40 Index (the Underlying Index).
Top 10 holdings.
| Holding | % of fund |
|---|---|
| Innovent Biologics, Inc. | 8.69% |
| BeOne Medicines AG | 8.17% |
| Wuxi Biologics (Cayman) Inc. | 6.63% |
| Akeso Inc | 5.74% |
| WuXi AppTec Co., Ltd. | 5.68% |
| Jiangsu Hengrui Pharmaceuticals Co.,Ltd | 4.58% |
| Shenzhen Mindray Bio-Medical Electronics Co Ltd | 4.29% |
| Sino Biopharmaceutical Limited | 4.18% |
| Cspc Pharmaceutical Group Limited | 3.61% |
| Hansoh Pharmaceutical Group Company Limited | 3.59% |
More on KURE.
- KURE overview
- KURE holdings
- KURE risk
- KURE costs
- KURE money in and out
- KURE share classes
- Compare KURE with other funds
Returns after fees, from the fund's SEC filings up to Aug 2026. Past returns are not a promise. Not financial advice.